Shariq Ali Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
PhD Reseacher/ Research Assitant
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Shariq Ali's research encompasses several areas, including the pharmacological effects of compounds and their transfer into specific biological tissues, such as the human placenta. He has investigated the formulation effects on paclitaxel transfer and uptake in the placenta and explored the potential of plant extracts, like Symphorema polyandrum Wight, for antioxidant, anticancer, and anti-inflammatory properties. Ali's work also extends to medical imaging, with research on modulating microbubbles for ultrasound imaging. Additionally, his publications indicate an interest in drug discovery, particularly concerning the prevalence and role of halogens in pharmaceutical development. Ali has contributed to studies on cancer treatment, including preliminary clinical response data for novel drug combinations in Waldenström's Macroglobulinemia. His scholarship metrics include an h-index of 14, with 48 total publications and 1,264 citations.
Metrics
- h-index: 14
- Publications: 47
- Citations: 1,271
Selected Publications
-
Programmable Metal–Organic Complex Arrays with Precisely Controlled Metal Sequences as Tunable Multinuclear Scaffolds (2026)
-
Tailoring of Cerium Oxide Nanosheets Having Superior Peroxidase Catalytic Activity for Colorimetric Detection of Hydrogen Peroxide (2026)
Collaboration Network
Top Collaborators
- Modulating Nonlinear Acoustic Response of Phospholipid-Coated Microbubbles with pH for Ultrasound Imaging
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Development of Improved Liver Steatosis Phantoms for Accurate Histopathologic Representation and Multimodal Imaging
- Modulating Nonlinear Acoustic Response of Phospholipid-Coated Microbubbles with pH for Ultrasound Imaging
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Development of Improved Liver Steatosis Phantoms for Accurate Histopathologic Representation and Multimodal Imaging
- Modulating Nonlinear Acoustic Response of Phospholipid-Coated Microbubbles with pH for Ultrasound Imaging
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Development of Improved Liver Steatosis Phantoms for Accurate Histopathologic Representation and Multimodal Imaging
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Development of Improved Liver Steatosis Phantoms for Accurate Histopathologic Representation and Multimodal Imaging
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Development of Improved Liver Steatosis Phantoms for Accurate Histopathologic Representation and Multimodal Imaging
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Lipid Microparticle‐Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques
- Quality of Life and Treatment Satisfaction in People With Haemophilia on Fitusiran Prophylaxis: Evidence From a Subset of ATLAS‐OLE Trial Participants Mainly From India
- EE293 Cost-Savings Assessment of Fitusiran Prophylaxis in Minimizing Breakthrough Bleeding Treatment Expenses in the United Arab Emirates
- EE292 Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia
- Preliminary Clinical Response Data from a Phase 1b Study of Mavorixafor in Combination with Ibrutinib in Patients with Waldenström's Macroglobulinemia with <i>MYD88</i> and <i>CXCR4</i> Mutations
- Prevalence of Chronic Neutropenic Disorders in the United States: A Retrospective Analysis of a Large Claims Database
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Tissue-Mimicking Phantom for Liver Fat Quantification
- Evaluating the safety and tolerability of switching from emicizumab to fitusiran prophylaxis in adult males with severe hemophilia A, with or without inhibitors: SWITCH study, a trial in progress
- Comparison of hemosil and innovance antithrombin assays using Hemophilia A plasma and antithrombin lowering (to mimic fitusiran)
- EE293 Cost-Savings Assessment of Fitusiran Prophylaxis in Minimizing Breakthrough Bleeding Treatment Expenses in the United Arab Emirates
- EE292 Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia
Similar Researchers
Based on overlapping research topics